Sciele Pharma to Webcast Product Development Pipeline Presentation
Posted on: Monday, 26 November 2007, 18:00 CST
Sciele Pharma, Inc. (NASDAQ:SCRX), a specialty pharmaceutical company, today announced that it will webcast its product development pipeline presentation in New York City on Thursday, November 29, 2007, at 12:30 p.m. Eastern Time. Speakers and topics include:
Patrick Fourteau - President and Chief Executive Officer of Sciele Pharma: Opening Remarks
Larry Dillaha M.D. - Executive Vice President & Chief Medical Officer: Sciele Pharma
(Glycopyrrolate and Pravastatin/Fenofibrate Combination)
Mike Precopio - Chief Executive Officer: Summers Laboratories Inc.
(Head Lice Asphyxiation Product)
Moise Khayrallah Ph.D. - President & Chief Executive Officer: Addrenex Pharmaceuticals Inc.
(Clonicel for Hypertension and ADHD)
Dr. Michael Wyllie - Chief Scientific Officer: Plethora Solutions Limited
(PSD502 - For Premature Ejaculation)
The presentation will be available via webcast and may be accessed from the Investor section of the Company's website, www.sciele.com. The presentations will be available for replay for seven days using the same link.
Sciele Pharma, Inc. Background
Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Heath and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatric products treat allergies, asthma, coughs and colds, and attention deficit and hyperactivity disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Sciele Pharma employs more than 900 people. The Company's success is based upon placing the needs of patients first, improving health and quality of life, and implementing its business platform-an Entrepreneurial Spirit, Innovation, Speed of Execution, Simplicity and Teamwork.
Source: Business Wire
Related Articles
- New Chief Executive Officer Joins International Diabetes Federation
- Zealand Pharma Today Announced That Dr. David H Solomon Has Been Appointed Chief Executive Officer
- A.P. Pharma Appoints Ronald J. Prentki As President, Chief Executive Officer and Member of Its Board of Directors
- Edward J. Schutter Appointed to President and Chief Operating Officer of Sciele Pharma, Inc.
- DRAXIS Health Inc. Announces Retirement of Dr. Martin Barkin As President and Chief Executive Officer
- Gay Men's Health Crisis Chief Executive Officer to Ring the NASDAQ Stock Market Closing Bell to Honor AIDS Walk New York
- Health Net Names Mark El-Tawil Chief Senior Products Officer
- Sciele Pharma Introduces OSTIVA(TM), a New Women's Health Product
- Inpatient Medical Services Changes Name to Intercede Health - Company to Focus on Integrated Medical Management; New Name, New Leadership - Intercede Health Recruits New Chief Executive Officer
- New Women's Health Research Findings From NIH Highlighted in Journal of Women's Health
 |
 |
User Comments (0)
RSS Feeds